Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INAB In8Bio Inc
- Stocks
- Healthcare
- NASDAQ: INAB
Price (delayed)
$2.15
Market cap
$6.51M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$13.5
Enterprise value
-$1.11M
Highlights
The EPS has soared by 51% YoY and by 21% QoQ
In8Bio's debt has decreased by 25% YoY and by 15% from the previous quarter
In8Bio's equity has decreased by 21% YoY and by 4.2% from the previous quarter
Key stats
What are the main financial stats of INAB
Market
Valuations
Earnings
Shares outstanding
3.03M
Market cap
$6.51M
Enterprise value
-$1.11M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$27.68M
Net income
-$27.43M
EBIT
-$27.43M
EBITDA
-$24.73M
Free cash flow
-$19.47M
Per share
Balance sheet
Liquidity
EPS
-$13.5
EPS diluted
-$13.5
Free cash flow per share
-$7
Book value per share
$5.12
Revenue per share
$0
TBVPS
$7.14
Total assets
$19.87M
Total liabilities
$5.99M
Debt
$4.27M
Equity
$13.88M
Working capital
$9.77M
Debt to equity
0.31
Current ratio
4.3
Quick ratio
4.02
Net debt/EBITDA
0.31
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-138.4%
Return on equity
-217%
Return on invested capital
-227.2%
Return on capital employed
-162.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INAB stock price
How has the In8Bio stock price performed over time
Intraday
-0.46%
1 week
-0.46%
1 month
-42.05%
1 year
-91.03%
YTD
-72.15%
QTD
2.87%
Financial performance
How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.68M
Net income
-$27.43M
Gross margin
N/A
Net margin
N/A
INAB's net income is up by 12% YoY and by 10% from the previous quarter
INAB's operating income is up by 11% year-on-year and by 10% since the previous quarter
Price vs fundamentals
How does INAB's price correlate with its fundamentals
Growth
What is In8Bio's growth rate over time
Valuation
What is In8Bio stock price valuation
P/E
N/A
P/B
0.42
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 51% YoY and by 21% QoQ
INAB's P/B is 74% below its last 4 quarters average of 1.6
In8Bio's equity has decreased by 21% YoY and by 4.2% from the previous quarter
Efficiency
How efficient is In8Bio business performance
The return on equity has declined by 43% year-on-year but it has grown by 3.4% since the previous quarter
The ROA has decreased by 28% YoY but it has increased by 3.4% from the previous quarter
Dividends
What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INAB.
Financial health
How did In8Bio financials performed over time
In8Bio's total liabilities has decreased by 25% YoY and by 7% QoQ
The total assets has declined by 22% year-on-year and by 5% since the previous quarter
In8Bio's debt is 69% less than its equity
In8Bio's debt has decreased by 25% YoY and by 15% from the previous quarter
In8Bio's equity has decreased by 21% YoY and by 4.2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.